Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
SPARC Stock Analysis
Views
Red Flags
Positive
Not enough talking point with positive stance
Negative
Stock is fairly expensive with negative EPS on a trailing 12-month basis
Low dividend yield
Neutral
Company's earnings are of moderate quality
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
SPARC Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
SPARC Bulk, Block & Insider Trades
SPARC Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No dividend events found
Rights issue
Rights issue(5 new shares @ 245 INR for 116 existing shares) Ex-date: 16th Mar 2016 Announced on: 5th Mar 2016
Rights issue(1 new shares @ 67 INR for 7 existing shares)Book closure start date 25 August 2012 and book closure end date 27 August 2012. Offer price is inclusive of premium of INR 66. Ex-date: 23rd Aug 2012 Announced on: 10th Aug 2012
Company Profile
Sun Pharma Advanced Research Company Limited is an India-based clinical-stage biopharmaceutical company that focuses on developing therapeutics to improve standards of care for patients worldwide. The Company’s therapeutic focus is in the area of oncology, neurology and immunology. Its lead oncology... Read More
Key personnel
Mr. Dilip Shantilal ShanghviD
Non-Executive Chairman of the Board
Mr. Anilkumar Raghavan
Chief Executive Officer
Mr. Anup Rathi
Chief Financial Officer
Ms. Kajal Kiran Damania
Compliance Officer, Company Secretary
Dr. Thennati RajamannarD
Non-Executive Director
Ms. Vidhi Dilip ShanghviD
Non-Executive Director
Smt. Bhavna Gautam DoshiD
Non-Executive Independent Director
Dr. Ferzaan Nariman Engineer, Ph.D.D
Non-Executive Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Sun Pharma Advanced Research Company Ltd.?
The current share price of Sun Pharma Advanced Research Company Ltd. is ₹ 128.61 as of 23 Jan 2026.
What is the PE ratio of Sun Pharma Advanced Research Company Ltd.?
The Price-to-Earnings (PE) ratio of Sun Pharma Advanced Research Company Ltd. is - as of the latest financial data.
What is the ROE and ROCE of Sun Pharma Advanced Research Company Ltd.?
Sun Pharma Advanced Research Company Ltd. has a Return on Equity (ROE) of - and a Return on Capital Employed (ROCE) of -280.92% as per the latest financial reports.
What is the market cap of Sun Pharma Advanced Research Company Ltd.?
The market capitalization of Sun Pharma Advanced Research Company Ltd. stands at ₹ 4,173.68 Cr.
What is the dividend yield of Sun Pharma Advanced Research Company Ltd.?
The dividend yield of Sun Pharma Advanced Research Company Ltd. is 0.00% based on the current market price.
What is the RSI of Sun Pharma Advanced Research Company Ltd.?
The Relative Strength Index (RSI) of Sun Pharma Advanced Research Company Ltd. is 41.11.
What is the FII and DII holding in Sun Pharma Advanced Research Company Ltd.?
Foreign Institutional Investors (FII) hold 2.04% and Domestic Institutional Investors (DII) hold 0.76% of Sun Pharma Advanced Research Company Ltd. shares.
What sector does Sun Pharma Advanced Research Company Ltd. belong to?
Sun Pharma Advanced Research Company Ltd. operates in the Healthcare sector.
What is the beta of Sun Pharma Advanced Research Company Ltd. stock?
The beta of Sun Pharma Advanced Research Company Ltd. stock is 1.35, indicating its volatility relative to the broader market.
